At the American Diabetes Association meeting in New Orleans, Lilly presented more detailed trial data for its once-weekly injection retatrutide
A higher permeability across the BBB model was measured for targeted nanocarriers
Dong T, Chen X, Xu H, Song Y, Wang H, Gao Y, et al
BPC-157 Capsules vs Injections: Side-by-Side Comparison Absorption, Convenience, and Provider Guidance: What Actually Matters When patients compare BPC-157 capsules and injections, two things usually come up first: how well it absorbs, and how easy it is to take
Another common side effect is lack of appetite, to the point where some patients need to remind themselves to eat